Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAM

Clinical trial NCT03784547 · UNKNOWN

Trial details

NCT number: NCT03784547
Sponsor: Hospital Italiano de Buenos Aires
Status: UNKNOWN
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2019-02-01
Primary completion: 2019-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.